KFDA to support off-label use of medications

The Korea Food and Drug Administration plans to provide a variety of incentives to an applicant intends to initiate new clinical trials of off-label drugs to generate additional data for approval agencies to expand indications of proprietary drugs.

Off-label use is the practice of prescribing pharmaceuticals for an unapproved indication.

KFDA officials said the government will support th...